Plasmacytoid dendritic cells: Biomarkers or potential therapeutic targets in atherosclerosis?

Pharmacology and Therapeutics

Volumn 137, Issue 2, 2013, Pages 172-182

  Grassia, Gianluca ^a,b   MacRitchie, Neil ^b   Platt, Andrew M ^b   Brewer, James M ^b   Garside, Paul ^b   Maffia, Pasquale ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Atherosclerosis; Autoimmunity; Interferons; Plasmacytoid dendritic cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTIVE IMMUNITY; ARTERY; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CELL MATURATION; COMORBIDITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; ELECTRON MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTERIES; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DENDRITIC CELLS; HUMANS;

EID: 84872806688     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.10.001     Document Type: Review

References (171)

1. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui Recent advances on the role of cytokines in atherosclerosis Arterioscler Thromb Vasc Biol 31 2011 969 979
2. J.S. Allen, K. Pang, A. Skowera, R. Ellis, C. Rackham, and B. Lozanoska-Ochser Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture Diabetes 58 2009 138 145
3. H. Amuro, T. Ito, R. Miyamoto, H. Sugimoto, Y. Torii, and Y. Son Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production Arthritis Rheum 62 2010 2073 2085
4. M. Arpinati, G. Chirumbolo, B. Urbini, G. Perrone, D. Rondelli, and C. Anasetti Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation Transpl Immunol 11 2003 345 356
5. M. Arpinati, C.L. Green, S. Heimfeld, J.E. Heuser, and C. Anasetti Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 95 2000 2484 2490
6. Y. Asanuma, C.P. Chung, A. Oeser, A. Shintani, E. Stanley, and P. Raggi Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors J Rheumatol 33 2006 539 545
7. C. Asselin-Paturel, A. Boonstra, M. Dalod, I. Durand, N. Yessaad, and C. Dezutter-Dambuyant Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology Nat Immunol 2 2001 1144 1150
8. C. Asselin-Paturel, G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, and A. Vicari Type I interferon dependence of plasmacytoid dendritic cell activation and migration J Exp Med 201 2005 1157 1167
9. C. Auffray, D.K. Fogg, E. Narni-Mancinelli, B. Senechal, C. Trouillet, and N. Saederup CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation J Exp Med 206 2009 595 606
10. U. Bave, M. Magnusson, M.L. Eloranta, A. Perers, G.V. Alm, and L. Rönnblom Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG J Immunol 171 2003 3296 3302
11. U. Bave, H. Vallin, G.V. Alm, and L. Ronnblom Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines J Autoimmun 17 2001 71 80
12. P. Bjorck Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice Blood 98 2001 3520 3526
13. A.L. Blasius, M. Cella, J. Maldonado, T. Takai, and M. Colonna Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12 Blood 107 2006 2474 2476
14. A.L. Blasius, E. Giurisato, M. Cella, R.D. Schreiber, A.S. Shaw, and M. Colonna Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation J Immunol 177 2006 3260 3265
15. A. Blasius, W. Vermi, A. Krug, F. Facchetti, M. Cella, and M. Colonna A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha Blood 103 2004 4201 4206
16. B. Blom, S. Ho, S. Antonenko, and Y.J. Liu Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells J Exp Med 192 2000 1785 1796
17. L. Branen, L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 24 2004 2137 2142
18. P. Brawand, D.R. Fitzpatrick, B.W. Greenfield, K. Brasel, C.R. Maliszewski, and T. De Smedt Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs J Immunol 169 2002 6711 6719
19. M.J. Butcher, and E.V. Galkina Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta Front Physiol 3 2012 44
20. M. Cella, F. Facchetti, A. Lanzavecchia, and M. Colonna Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization Nat Immunol 1 2000 305 310
21. M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, and A. Lanzavecchia Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon Nat Med 5 1999 919 923
22. V.S. Chan, Y.J. Nie, N. Shen, S. Yan, M.Y. Mok, and C.S. Lau Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus Autoimmun Rev 11 2012 890 897
23. J. Chan, L. Prado-Lourenco, L.M. Khachigian, M.R. Bennett, B.A. Di Bartolo, and M.M. Kavurma TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner Circ Res 106 2010 1061 1071
24. C. Cheong, and J.H. Choi Dendritic cells and regulatory T cells in atherosclerosis Mol Cells 2012, Jun 28 [Epub ahead of print]
25. M. Colonna, G. Trinchieri, and Y.L. Liu Plasmacytoid dendritic cells in immunity Nat Immunol 5 2004 1219 1226
26. P. Conigliaro, C. Perricone, R.A. Benson, P. Garside, J.M. Brewer, and R. Perricone The type I IFN system in rheumatoid arthritis Autoimmunity 43 2010 220 225
27. T. Couffinhal, M. Kearney, B. Witzenbichler, D. Chen, T. Murohara, and D.W. Losordo Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries Am J Pathol 150 1997 1673 1685
28. M.K. Crow Type I interferon in organ-targeted autoimmune and inflammatory diseases Arthritis Res Ther 12 2010 S5
29. M.I. Cybulsky, and J. Jongstra-Bilen Resident intimal dendritic cells and the initiation of atherosclerosis Curr Opin Lipidol 21 2010 397 403
30. I.T. Daissormont, A. Christ, L. Temmerman, S. Sampedro Millares, T. Seijkens, and M. Manca Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity Circ Res 109 2011 1387 1395
31. A. Daugherty, and D.L. Rateri Development of experimental designs for atherosclerosis studies in mice Methods 36 2005 129 138
32. H.J. De Heer, H. Hammad, T. Soullié, D. Hijdra, N. Vos, and M.A. Willart Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen J Exp Med 200 2004 89 98
33. F. Del Porto, B. Lagana, S. Lai, I. Nofroni, F. Tinti, and M. Vitale Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis Rheumatology (Oxford) 46 2007 1111 1115
34. M.F. Denny, S. Thacker, H. Mehta, E.C. Somers, T. Dodick, and F.J. Barrat Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis Blood 110 2007 2907 2915
35. - mice Diabetologia 54 2011 3157 3167
36. J. Diana, V. Brezar, L. Beaudoin, M. Dalod, A. Mellor, and A. Tafuri Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay J Exp Med 208 2011 729 745
37. Y. Döring, H.D. Manthey, M. Drechsler, D. Lievens, R.T. Megens, and O. Soehnlein Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis Circulation 125 2012 1673 1683
38. Y. Döring, and A. Zernecke Plasmacytoid dendritic cells in atherosclerosis Front Physiol 3 2012 230
39. A. Dzionek, A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, and S. Miltenyi BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood J Immunol 165 2000 6037 6046
40. A. Dzionek, Y. Sohma, J. Nagafune, M. Cella, M. Colonna, and F. Facchetti BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction J Exp Med 194 2001 1823 1834
41. S.E. Epstein, J. Zhu, M.S. Burnett, Y.F. Zhou, G. Vercellotti, and D. Hajjar Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry Arterioscler Thromb Vasc Biol 20 2000 1417 1420
42. D. Fabricius, and B. Jahrsdörfer Approaches to the pharmacological modulation of plasmacytoid dendritic cells Endocr Metab Immune Disord Drug Targets 11 2011 154 164
43. P. Fabris, A. Floreani, G. Tositti, D. Vergani, F. De Lalla, and C. Betterle Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy Aliment Pharmacol Ther 18 2003 549 558
44. F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, and C. Asselin-Paturel Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells Int Immunol 17 2005 1429 1438
45. L. Farkas, K. Beiske, F. Lund-Johansen, P. Brandtzaeg, and F.L. Jahnsen Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions Am J Pathol 159 2001 237 243
46. M. Feldmann, and R.N. Maini Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases Nat Med 9 2003 1245 1250
47. G.A. Ferreira, T.P. Navarro, R.W. Telles, L.E. Andrade, and E.I. Sato Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial Rheumatology (Oxford) 46 2007 1560 1565
48. D.K. Fogg, C. Sibon, C. Miled, S. Jung, P. Aucouturier, and D.R. Littman A clonogenic bone marrow progenitor specific for macrophages and dendritic cells Science 311 2006 83 87
49. L.E. Full, and C. Monaco Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis Cardiovasc Ther 29 2011 231 242
50. E. Galkina, and K. Ley Immune and inflammatory mechanisms of atherosclerosis Annu Rev Immunol 27 2009 165 197
51. M. Gilliet, A. Boonstra, C. Paturel, S. Antonenko, X.L. Xu, and G. Trinchieri The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor J Exp Med 195 2002 953 958
52. M. Gilliet, W. Cao, and Y.J. Liu Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases Nat Rev Immunol 8 2008 594 606
53. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo, C. Garcia-Porrua, J. Llorca, and M.A. Gonzalez-Gay Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 2004 447 450
54. P. Goossens, M.J. Gijbels, A. Zernecke, W. Eijgelaar, M.N. Vergouwe, and I. van der Made Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions Cell Metab 12 2010 142 153
55. J. Grisar, C.W. Steiner, M. Bonelli, T. Karonitsch, I. Schwarzinger, and G. Weigel Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells Rheumatology (Oxford) 47 2008 1476 1483
56. G. Grouard, M.C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y.J. Liu The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand J Exp Med 185 1997 1101 1111
57. K.L. Habets, G.H. van Puijvelde, L.M. van Duivenvoorde, E.J. van Wanrooij, P. de Vos, and J.W. Tervaert Vaccination using oxidized low density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice Cardiovasc Res 85 2010 622 630
58. H. Hadeiba, K. Lahl, A. Edalati, C. Oderup, A. Habtezion, and R. Pachynski Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance Immunity 36 2012 438 450
59. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
60. E.J. Hennessy, A.E. Parker, and L.A. O'Neill Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9 2010 293 307
61. A. Hermansson, D.K. Johansson, D.F. Ketelhuth, J. Andersson, X. Zhou, and G.K. Hansson Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells atte-nuates atherosclerosis in hypercholesterolemic mice Circulation 123 2011 1083 1091
62. B.W. Higgs, W. Zhu, L. Richman, D.F. Fiorentino, S.A. Greenberg, and B. Jallal Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients Int J Rheum Dis 15 2012 25 35
63. J.J. Hooks, H.M. Moutsopoulos, S.A. Geis, N.I. Stahl, J.L. Decker, and A.L. Notkins Immune interferon in the circulation of patients with autoimmune disease N Engl J Med 301 1979 5 8
64. D. Hurlimann, F. Enseleit, and F. Ruschitzka Rheumatoid arthritis, inflammation, and atherosclerosis Herz 29 2004 760 768
65. C. Ionescu, L. Micu, I. Constantinescu, M. Hortopan, C. Ursaciuc, and M. Voiculescu Prolonged treatment with interferon alpha and peginterferon induces rheumatoid arthritis syndrome and erythema nodosum J Gastrointestin Liver Dis 17 2008 211 212
66. M. Irla, N. Küpfer, T. Suter, R. Lissilaa, M. Benkhoucha, and J. Skupsky MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity J Exp Med 207 2010 1891 1905
67. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 2004 987 995
68. Y. Izumi, A. Komori, Y. Yasunaga, S. Hashimoto, T. Miyashita, and S. Abiru Rheumatoid arthritis following a treatment with IFN-alpha/ribavirin against HCV infection Intern Med 50 2011 1065 1068
69. L.T. Jacobsson, C. Turesson, A. Gulfe, M.C. Kapetanovic, I.F. Petersson, and T. Saxne Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis J Rheumatol 32 2005 1213 1218
70. F.L. Jahnsen, F. Lund-Johansen, J.F. Dunne, L. Farkas, R. Haye, and P. Brandtzaeg Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy J Immunol 165 2000 4062 4068
71. B. Jahrsdörfer, A. Vollmer, S.E. Blackwell, J. Maier, K. Sontheimer, and T. Beyer Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion Blood 115 2010 1156 1165
72. G. Jego, A.K. Palucka, J.P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 Immunity 19 2003 225 234
73. S.L. Jongbloed, R.A. Benson, M.B. Nickdel, P. Garside, I.B. McInnes, and J.M. Brewer Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis J Immunol 182 2009 963 968
74. N. Kadowaki, S. Antonenko, J.Y. Lau, and Y.J. Liu Natural interferon alpha/beta-producing cells link innate and adaptive immunity J Exp Med 192 2000 219 226
75. N. Kadowaki, S. Ho, S. Antonenko, R.W. Malefyt, R.A. Kastelein, and F. Bazan Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J Exp Med 194 2001 863 869
76. M.L. Kalb, A. Glaser, G. Stary, F. Koszik, and G. Stingl TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity J Immunol 188 2012 1583 1591
77. M. Kavousanaki, A. Makrigiannakis, D. Boumpas, and P. Verginis Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10- producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy Arthritis Rheum 62 2010 53 63
78. M.M. Kavurma, M. Schoppet, Y.V. Bobryshev, L.M. Khachigian, and M.R. Bennett TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor J Biol Chem 283 2008 7754 7762
79. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat Immunol 11 2010 373 384
80. K.A. Kirou, C. Lee, S. George, K. Louca, I.G. Papagiannis, and M.G. Peterson Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus Arthritis Rheum 50 2004 3958 3967
81. K.A. Kirou, C. Lee, S. George, K. Louca, M.G. Peterson, and M.K. Crow Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis Rheum 52 2005 1491 1503
82. G.D. Kitas, and S.E. Gabriel Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives Ann Rheum Dis 70 2011 8 14
83. E.K. Koltsova, and K. Ley How dendritic cells shape atherosclerosis Trends Immunol 32 2011 540 547
84. A. Krug, A.R. French, W. Barchet, J.A. Fischer, A. Dzionek, and J.T. Pingel TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function Immunity 21 2004 107 119
85. A. Krug, R. Uppaluri, F. Facchetti, B.G. Dorner, K.C. Sheehan, and R.D. Schreiber IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation J Immunol 169 2002 6079 6083
86. M. Kuwana, J. Kaburaki, T.M. Wright, Y. Kawakami, and Y. Ikeda Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors Eur J Immunol 31 2001 2547 2557
87. R. Lande, D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, and J. Gregorio Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus Sci Transl Med 3 2011 73ra19
88. R. Lande, E. Giacomini, B. Serafini, B. Rosicarelli, G.D. Sebastiani, and G. Minisola Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis J Immunol 173 2004 2815 2824
89. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H. Wang, and B. Homey Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 449 2007 564 569
90. M.C. Lebre, S.L. Jongbloed, S.W. Tas, T.J. Smeets, I.B. McInnes, and P.P. Tak Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles Am J Pathol 172 2008 940 950
91. A.B. Lee, T. Godfrey, K.G. Rowley, C.S. Karschimkus, G. Dragicevic, and E. Romas Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus Intern Med J 36 2006 237 243
92. P.Y. Lee, Y. Li, H.B. Richards, F.S. Chan, H. Zhuang, and S. Narain Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus Arthritis Rheum 56 2007 3759 3769
93. J. Li, Q. Fu, H. Cui, B. Qu, W. Pan, and N. Shen Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-alpha and atherosclerosis in lupus Arthritis Rheum 63 2011 492 502
94. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
95. K. Liu, G.D. Victora, T.A. Schwickert, P. Guermonprez, M.M. Meredith, and K. Yao In vivo analysis of dendritic cell development and homeostasis Science 324 2009 392 397
96. C. Lood, S. Amisten, B. Gullstrand, A. Jönsen, M. Allhorn, and L. Truedsson Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease Blood 116 2010 1951 1957
97. J. Loschko, S. Heink, D. Hackl, D. Dudziak, W. Reindl, and T. Korn Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity J Immunol 187 2011 6346 6356
98. T. Lovgren, M.L. Eloranta, U. Bave, G.V. Alm, and L. Ronnblom Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG Arthritis Rheum 50 2004 1861 1872
99. F. Mach, A. Sauty, A.S. Iarossi, G.K. Sukhova, K. Neote, and P. Libby Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells J Clin Invest 104 1999 1041 1050
100. N. Macritchie, G. Grassia, S.R. Sabir, M. Maddaluno, P. Welsh, and N. Sattar Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 32 2012 2569 2579
101. O. Manches, D. Munn, A. Fallahi, J. Lifson, L. Chaperot, and J. Plumas HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism J Clin Invest 8 2008 3431 3439
102. H.D. Manthey, and A. Zernecke Dendritic cells in atherosclerosis: functions in immuneregulation and beyond Thromb Haemost 106 2011 772 778
103. S. Manzi, F. Selzer, K. Sutton-Tyrrell, S.G. Fitzgerald, J.E. Rairie, and R.P. Tracy Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus Arthritis Rheum 42 1999 51 60
104. P. Martín, G.M. Del Hoyo, F. Anjuère, C.F. Arias, H.H. Vargas, and A. Fernández-L Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential Blood 100 2002 383 390
105. G.E. McKellar, D.W. McCarey, N. Sattar, and I.B. McInnes Role for TNF in atherosclerosis? Lessons from autoimmune disease Nat Rev Cardiol 6 2009 410 417
106. T.K. Means, E. Latz, F. Hayashi, M.R. Murali, D.T. Golenbock, and A.D. Luster Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 J Clin Invest 115 2005 407 417
107. J.T. Merrill, D.J. Wallace, M. Petri, K.A. Kirou, Y. Yao, and W.I. White Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study Ann Rheum Dis 70 2011 1905 1913
108. K. Migita, T. Miyashita, Y. Maeda, H. Kimura, M. Nakamura, and H. Yatsuhashi Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus Clin Exp Immunol 142 2005 84 91
109. M. Mittelbrunn, G. Martínez del Hoyo, M. López-Bravo, N.B. Martín-Cofreces, A. Scholer, and S. Hugues Imaging of plasmacytoid dendritic cell interactions with T cells Blood 113 2009 75 84
110. I. Moldovan, and E. Katsaros Recent developments in the treatment of lupus disease Eur Musculoskelet Rev 7 2012 18 21
111. J.R. Moonen, K. de Leeuw, X.J. van Seijen, C.G. Kallenberg, M.J. van Luyn, and M. Bijl Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus Arthritis Res Ther 9 2007 R84
112. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
113. E.A. Moseman, X. Liang, A.J. Dawson, A. Panoskaltsis-Mortari, A.M. Krieg, and Y.J. Liu Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells J Immunol 173 2004 4433 4442
114. S.N. Mueller, V.K. Vanguri, S.J. Ha, E.E. West, M.E. Keir, and J.N. Glickman PD-L1 has distinct functions in hematopoietic and non-hematopoietic cells in regulating T cell responses during chronic infection in mice J Clin Invest 120 2010 2508 2515
115. A. Niessner, K. Sato, E.L. Chaikof, I. Colmegna, J.J. Goronzy, and C.M. Weyand Pathogen sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha Circulation 114 2006 2482 2489
116. A. Niessner, M.S. Shin, O. Pryshchep, J.J. Goronzy, E.L. Chaikof, and C.M. Weyand Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque Circulation 116 2007 2043 2052
117. A. Niessner, and C.M. Weyand Dendritic cells in atherosclerotic disease Clin Immunol 134 2010 25 32
118. T. Nikolic, J.M. Welzen-Coppens, P.J. Leenen, H.A. Drexhage, and M.A. Versnel Plasmacytoid dendritic cells in autoimmune diabetes: potential tools for immunotherapy Immunobiology 214 2009 791 799
119. J.C. Ochando, C. Homma, Y. Yang, A. Hidalgo, A. Garin, and F. Tacke Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts Nat Immunol 7 2006 652 662
120. M. O'Keeffe, H. Hochrein, D. Vremec, I. Caminschi, J.L. Miller, and E.M. Anders Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus J Exp Med 196 2002 1307 1319
121. E. Passos de Souza, P.T. Evangelista Segundo, F.F. Jose, D. Lemaire, and M. Santiago Rheumatoid arthritis induced by alpha-interferon therapy Clin Rheumatol 20 2001 297 299
122. P. Puddu, G.M. Puddu, E. Cravero, S. Muscari, and A. Muscari The functional role of dendritic cells in atherogenesis Mol Med Rep 3 2010 551 554
123. B. Pulendran, J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, and C. Chalouni Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo J Immunol 165 2000 566 572
124. S. Rajagopalan, E.C. Somers, R.D. Brook, C. Kehrer, D. Pfenninger, and E. Lewis Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity Blood 103 2004 3677 3683
125. B. Reizis, M. Colonna, G. Trinchieri, F. Barrat, and M. Gilliet Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol 11 2011 558 565
126. Y.H. Rho, C.P. Chung, A. Oeser, J. Solus, P. Raggi, and T. Gebretsadik Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus J Rheumatol 35 2008 1789 1794
127. E. Riboldi, R. Daniele, M.A. Cassatella, S. Sozzani, and D. Bosisio Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells Immunobiology 214 2009 868 876
128. M.C. Rissoan, T. Duhen, J.M. Bridon, N. Bendriss-Vermare, C. Péronne, and B. de Saint Vis Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells Blood 100 2002 3295 3303
129. M.F. Roelofs, M.H. Wenink, F. Brentano, S. Abdollahi-Roodsaz, B. Oppers-Walgreen, and P. Barrera Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA) Ann Rheum Dis 68 2009 1486 1493
130. L. Rogge, D. D'Ambrosio, M. Biffi, G. Penna, L.J. Minetti, and D.H. Presky The role of Stat4 in species-specific regulation of Th cell development by type I IFNs J Immunol 161 1998 6567 6574
131. K.I. Rother, R.J. Brown, M.M. Morales, E. Wright, Z. Duan, and C. Campbell Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes Diabetes Care 32 2009 1250 1255
132. M. Salio, M.J. Palmowski, A. Atzberger, I.F. Hermans, and V. Cerundolo CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens J Exp Med 199 2004 567 579
133. S.M. Santini, C. Lapenta, M. Logozzi, S. Parlato, M. Spada, and T. Di Pucchio Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J Exp Med 191 2000 1777 1788
134. A. Sapoznikov, J.A. Fischer, T. Zaft, R. Krauthgamer, A. Dzionek, and S. Jung Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells J Exp Med 204 2007 1923 1933
135. K. Sato, A. Niessner, S.L. Kopecky, R.L. Frye, J.J. Goronzy, and C.M. Weyand TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque J Exp Med 203 2006 239 250
136. G. Schlecht, S. Garcia, N. Escriou, A.A. Freitas, C. Leclerc, and G. Dadaglio Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation Blood 104 2004 1808 1815
137. D.J. Schulte, A. Yilmaz, K. Shimada, M.C. Fishbein, E.L. Lowe, and S. Chen Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease J Immunol 183 2009 5311 5318
138. P. Secchiero, R. Candido, F. Corallini, S. Zacchigna, B. Toffoli, and E. Rimondi Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice Circulation 114 2006 1522 1530
139. H. Shi, J. Ge, W. Fang, K. Yao, A. Sun, and R. Huang Peripheral-blood dendritic cells in men with coronary heart disease Am J Cardiol 100 2007 593 597
140. S. Song, K. Choi, S.W. Ryu, S.W. Kang, and C. Choi TRAIL promotes caspase-dependent pro-inflammatory responses via PKCδ activation by vascular smooth muscle cells Cell Death Dis 2 2011 e223
141. R. Sorrentino, S. Morello, and A. Pinto Plasmacytoid dendritic cells: from heart to vessels Int J Vasc Med 2010 430318
142. Y. Sugi, H. Yasukawa, H. Kai, D. Fukui, N. Futamata, and K. Mawatari Reduction and activation of circulating dendritic cells in patients with decompensated heart failure Int J Cardiol 147 2011 258 264
143. E. Svenungsson, G.Z. Fei, K. Jensen-Urstad, U. de Faire, A. Hamsten, and J. Frostegard TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease Lupus 12 2003 454 461
144. M. Swiecki, and M. Colonna Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance Immunol Rev 234 2010 142 162
145. M. Swiecki, S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual Immunity 33 2010 955 966
146. H. Takagi, T. Fukaya, K. Eizumi, Y. Sato, K. Sato, and A. Shibazaki Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo Immunity 35 2011 958 971
147. J. Trapé, C. Morales, R. Molina, X. Filella, J.M. Marcos, and R. Salinas Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients Scand J Clin Lab Invest 66 2006 261 267
148. M.B. Urowitz, A.A. Bookman, B.E. Koehler, D.A. Gordon, H.A. Smythe, and M.A. Ogryzlo The bimodal mortality pattern of systemic lupus erythematosus Am J Med 60 1976 221 225
149. L.G. van Baarsen, W.H. Bos, F. Rustenburg, T.C. van der Pouw Kraan, G.J. Wolbink, and B.A. Dijkmans Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis Arthritis Rheum 62 2010 694 704
150. I. Van Brussel, E.A. Van Vré, G.R. De Meyer, C.J. Vrints, J.M. Bosmans, and H. Bult Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood J Immunol Methods 362 2010 168 175
151. T.C. van der Pouw Kraan, C.A. Wijbrandts, L.G. van Baarsen, A.E. Voskuyl, F. Rustenburg, and J.M. Baggen Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients Ann Rheum Dis 66 2007 1008 1014
152. C.H. Van Krinks, M.K. Matyszak, and J.S. Gaston Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid Rheumatology (Oxford) 43 2004 453 460
153. E.A. Van Vré, J.M. Bosmans, I. Van Brussel, M. Maris, G.R. De Meyer, and P.E. Van Schil Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls Pathology 43 2011 239 247
154. E.A. Van Vré, V.Y. Hoymans, H. Bult, M. Lenjou, D.R. Van Bockstaele, and C.J. Vrints Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease Coron Artery Dis 17 2006 243 248
155. E.A. Van Vré, I. Van Brussel, J.M. Bosmans, C.J. Vrints, and H.
156. E.A. Van Vré, I. Van Brussel, K.O. de Beeck, V.Y. Hoymans, C.J. Vrints, and H. Bult Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function Coron Artery Dis 21 2010 87 96
157. A.J. van Zonneveld, H.C. de Boer, E.P. van der Veer, and T.J. Rabelink Inflammation, vascular injury and repair in rheumatoid arthritis Ann Rheum Dis 69 2010 i57 i60
158. J.A. Villadangos, and L. Young Antigen-presentation properties of plasmacytoid dendritic cells Immunity 29 2008 352 361
159. C. Waskow, K. Liu, G. Darrasse-Jèze, P. Guermonprez, F. Ginhoux, and M. Merad The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues Nat Immunol 9 2008 676 683
160. V. Watt, J. Chamberlain, T. Steiner, S. Francis, and D. Crossman TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice Atherosclerosis 215 2011 348 354
161. M. Wendland, N. Czeloth, N. Mach, B. Malissen, E. Kremmer, and O. Pabst CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine Proc Natl Acad Sci U S A 104 2007 6347 6352
162. P.E. Westerweel, R.K. Luyten, H.A. Koomans, R.H. Derksen, and M.C. Verhaar Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus Arthritis Rheum 56 2007 1384 1396
163. A. Wollenberg, M. Wagner, S. Günther, A. Towarowski, E. Tuma, and M. Moderer Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases J Invest Dermatol 119 2002 1096 1102
164. C.J. Workman, Y. Wang, K.C. El Kasmi, D.M. Pardoll, P.J. Murray, and C.G. Drake LAG-3 regulates plasmacytoid dendritic cell homeostasis J Immunol 182 2009 1885 1891
165. P. Wu, J. Wu, S. Liu, X. Han, J. Lu, and Y. Shi TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients Clin Immunol 129 2008 40 48
166. M. Yamazaki, A. Sato, T. Takeda, and M. Komatsu Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C Intern Med 49 2010 403 407
167. A. Yilmaz, and M. Arditi Giant cell arteritis: dendritic cells take two T's to tango Circ Res 104 2009 425 427
168. A. Yilmaz, T. Schaller, I. Cicha, R. Altendorf, C. Stumpf, and L. Klinghammer Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease Clin Sci 116 2009 353 363
169. A. Yilmaz, J. Weber, I. Cicha, C. Stumpf, M. Klein, and D. Raithel Decrease in circulating myeloid dendritic cell precursors in coronary artery disease J Am Coll Cardiol 48 2006 70 80
170. U. Yrlid, V. Cerovic, S. Milling, C.D. Jenkins, J. Zhang, and P.R. Crocker Plasmacytoid dendritic cells do not migrate in intestinal or hepatic lymph J Immunol 177 2006 6115 6121
171. Z. Zhou, P. Subramanian, G. Sevilmis, B. Globke, O. Soehnlein, and E. Karshovska Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium Cell Metab 13 2011 592 600